Published 08:20 IST, August 26th 2020

Blood cancer patients face high risk of death from COVID compared to other cancers: Study

A study revealed that COVID-19 patients with blood cancer are more likely to have poor outcomes compared to patients with solid organ tumours.

Reported by: Vishal Tiwari
Follow: Google News Icon
  • share
null | Image: self
Advertisement

A study revealed that COVID-19 patients with blood cancer are more likely to have poor outcomes compared to patients with solid organ tumours. study published in Lancet Oncology found that fatality rate in patients with blood cancer was higher in comparison to patients with or s of cancers.

study, funded by University of Birmingham and University of Oxford, compared ult patients with cancer enrolled in UK Coronavirus Cancer Monitoring Project (UKCCMP) data between March 18 and May 8, with a parallel n-COVID-19 UK cancer control population from UK Office for National Statistics using its 2017 data.

Advertisement

Re: GeoVax Biotechlogy Firm Begins Early-st Study Of HIV Combination rapy

Risk associated with increasing

study found that blood cancer patients with coronavirus infection are significantly at higher risk of developing severe illness with an odd of 57 per cent compared to patients with or kinds of tumours. "Our data indicate that patients with cancer with different tumour s have variable SARS-CoV-2 susceptibility and COVID-19 disease phes, with table increased SARS-CoV-2 susceptibility in patients with haematological cancers," study said. It analysed over 1,000 COVID-19 patients with active cancer. study also found that fatality rate among patients with COVID-19 and active cancer was significantly associated with increasing , especially in those d 80 years and above. 

Advertisement

Re: Self-collected Saliva As Good As Deep Nasal Swabs For Diagsing COVID-19: Study

study discovered that men with active cancer were more likely to contract coronavirus as nearly 57 per cent of studied patients were male. study also said that COVID-19 patients with blood cancer were significantly more likely to require high flow oxygen, n-invasive ventilation, intensive care unit mission for ventilation, and have a severe or critical viral infection. Patients who h recent chemorapy h an increased risk of death during COVID-19-associated hospitalisation, said study, whose aim was to investigate COVID-19 risk according to tumour sub and patient demographics in patients with cancer. 

Advertisement

Re: BP Drugs May Improve COVID-19 Survival Rates, Study Says

Meanwhile, coronavirus pandemic, which originated from China's Wuhan city, is continuing to wreck havoc across globe with over 23.8 million confirmed cases and more than 8,15,000 deaths so far. According to figures by Johns Hopkins University, United States remains worst affected country in world with 5.7 million infections and at least 1,78,000 deaths to date. United States is followed by Brazil, India, Russia, and South Africa in terms of reported cases, while in terms of deaths, Brazil, Mexico, India, and United Kingdom le charts after rth American nation. 

Advertisement

Re: COVID-19: Hypertension Medicines May Improve Survival Chances, Says New Study

(Im Credit: AP)
 

Advertisement

08:20 IST, August 26th 2020